| Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between … PL Lakatos, PA Golovics, G David, T Pandur, Z Erdelyi, A Horvath, ... Official journal of the American College of Gastroenterology| ACG 107 (4 …, 2012 | 249 | 2012 |
| Efficacy and safety of the biosimilar infliximab CT-P13 treatment in inflammatory bowel diseases: a prospective, multicentre, nationwide cohort KB Gecse, BD Lovász, K Farkas, J Banai, L Bene, B Gasztonyi, ... Journal of Crohn's and Colitis 10 (2), 133-140, 2016 | 221 | 2016 |
| Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in … LS Kiss, T Szamosi, T Molnar, P Miheller, L Lakatos, A Vincze, K Palatka, ... Alimentary pharmacology & therapeutics 34 (8), 911-922, 2011 | 196 | 2011 |
| Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort PL Lakatos, Z Vegh, BD Lovasz, G David, T Pandur, Z Erdelyi, I Szita, ... Inflammatory bowel diseases 19 (5), 1010-1017, 2013 | 135 | 2013 |
| Efficacy of infliximab biosimilar CT-P13 induction therapy on mucosal healing in ulcerative colitis K Farkas, M Rutka, PA Golovics, Z Végh, BD Lovász, T Nyári, KB Gecse, ... Journal of Crohn's and Colitis 10 (11), 1273-1278, 2016 | 98 | 2016 |
| New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe BD Lovasz, PA Golovics, Z Vegh, PL Lakatos Digestive and Liver Disease 45 (4), 269-276, 2013 | 87 | 2013 |
| Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics MD Michael, A Bálint, BD Lovász, L Gulácsi, B Strbák, PA Golovics, ... The European Journal of Health Economics 15, 121-128, 2014 | 86 | 2014 |
| Evolution of disease phenotype in adult and pediatric onset Crohn’s disease in a population-based cohort BD Lovasz, L Lakatos, A Horvath, I Szita, T Pandur, M Mandel, Z Vegh, ... World Journal of Gastroenterology: WJG 19 (14), 2217, 2013 | 80 | 2013 |
| Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe Z Kurti, BD Lovasz, MD Mandel, Z Csima, PA Golovics, BD Csako, ... World journal of gastroenterology: WJG 21 (21), 6728, 2015 | 73 | 2015 |
| Inflammatory bowel disease course in Crohn’s disease: is the natural history changing? PA Golovics, MD Mandel, BD Lovasz, PL Lakatos World Journal of Gastroenterology: WJG 20 (12), 3198, 2014 | 68 | 2014 |
| Long-term efficacy, safety, and immunogenicity of biosimilar infliximab after one year in a prospective nationwide cohort L Gonczi, KB Gecse, Z Vegh, Z Kurti, M Rutka, K Farkas, PA Golovics, ... Inflammatory bowel diseases 23 (11), 1908-1915, 2017 | 61 | 2017 |
| Prediction of short-and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play the more … L Gonczi, Z Vegh, PA Golovics, M Rutka, KB Gecse, R Bor, K Farkas, ... Journal of Crohn's and Colitis 11 (6), 697-705, 2017 | 61 | 2017 |
| Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease Z Vegh, Z Kurti, L Gonczi, PA Golovics, BD Lovasz, I Szita, M Balogh, ... Scandinavian journal of gastroenterology 51 (7), 848-854, 2016 | 60 | 2016 |
| Is early limited surgery associated with a more benign disease course in Crohn’s disease? PA Golovics, L Lakatos, A Nagy, T Pandur, I Szita, M Balogh, C Molnar, ... World Journal of Gastroenterology: WJG 19 (43), 7701, 2013 | 58 | 2013 |
| Prevalence and predictors of hospitalization in Crohn’s disease in a prospective population-based inception cohort from 2000-2012 PA Golovics, L Lakatos, MD Mandel, BD Lovasz, Z Vegh, Z Kurti, I Szita, ... World Journal of Gastroenterology: WJG 21 (23), 7272, 2015 | 56 | 2015 |
| Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: a population-based study based on the National Health Insurance Fund database Z Kurti, Z Vegh, PA Golovics, P Fadgyas-Freyler, KB Gecse, L Gonczi, ... Digestive and liver disease 48 (11), 1302-1307, 2016 | 53 | 2016 |
| Risk of colorectal cancer in Crohn's disease patients with colonic involvement and stenosing disease in a population-based cohort from Hungary. BD Lovasz, L Lakatos, PA Golovics, G David, T Pandur, Z Erdelyi, ... Journal of Gastrointestinal & Liver Diseases 22 (3), 2013 | 50 | 2013 |
| Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011 BD Lovasz, L Lakatos, A Horvath, T Pandur, Z Erdelyi, M Balogh, ... Digestive and Liver Disease 46 (5), 405-411, 2014 | 48 | 2014 |
| Treatment preferences of originator versus biosimilar drugs in Crohn’s disease; discrete choice experiment among gastroenterologists P Baji, L Gulácsi, BD Lovász, PA Golovics, V Brodszky, M Péntek, ... Scandinavian Journal of Gastroenterology 51 (1), 22-27, 2016 | 43 | 2016 |
| Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: results from two referral centres MD Mandel, A Balint, PA Golovics, Z Vegh, A Mohas, B Szilagyi, A Szabo, ... Digestive and Liver Disease 46 (11), 985-990, 2014 | 38 | 2014 |
Peter Laszlo LakatosMcGill University and Semmelweis UniversityDirección de correo verificada de med.semmelweis-univ.hu